Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2021 Jun 2

PMID 34066710

Citations 11

Authors

Octav Ginghina

Ariana Hudita

Catalin Zaharia

Aristidis Tsatsakis

Yaroslav Mezhuev

Marieta Costache

Bianca Galateanu

Affiliations

Soon will be listed here.

Abstract

Globally, colorectal cancer (CRC) ranks as one of the most prevalent types of cancers at the moment, being the second cause of cancer-related deaths. The CRC chemotherapy backbone is represented by 5-fluorouracil, oxaliplatin, irinotecan, and their combinations, but their administration presents several serious disadvantages, such as poor bioavailability, lack of tumor specificity, and susceptibility to multidrug resistance. To address these limitations, nanomedicine has arisen as a powerful tool to improve current chemotherapy since nanosized carriers hold great promise in improving the stability and solubility of the drug payload and enhancing the active concentration of the drug that reaches the tumor tissue, increasing, therefore, the safety and efficacy of the treatment. In this context, the present review offers an overview of the most recent advances in the development of nanosized drug-delivery systems as smart therapeutic tools in CRC management and highlights the emerging need for improving the existing in vitro cancer models to reduce animal testing and increase the success of nanomedicine in clinical trials.

Citing Articles

Unraveling the mechanism of malancao in treating ulcerative colitis: A multi-omics approach.

Huang X, Wu L, Huang Q, Zhou Y, Qing L, Xiong F World J Clin Cases. 2024; 12(17):3105-3122.

PMID: 38898844 PMC: 11185383. DOI: 10.12998/wjcc.v12.i17.3105.

Assessment of the effects of amphiphilic poly (N‑vinylpyrrolidone) nanoparticles loaded with bortezomib on glioblastoma cell lines and zebrafish embryos.

Yagolovich A, Kuskov A, Kulikov P, Bagrov D, Petrova P, Kukovyakina E Biomed Rep. 2024; 20(3):37.

PMID: 38343660 PMC: 10853758. DOI: 10.3892/br.2024.1725.

Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer.

Abdellatif A, Alshubrumi A, Younis M AAPS PharmSciTech. 2024; 25(1):23.

PMID: 38267656 DOI: 10.1208/s12249-024-02734-9.

Cost-Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand.

Phisalprapa P, Kositamongkol C, Korphaisarn K, Akewanlop C, Srimuninnimit V, Supakankunti S Cancers (Basel). 2023; 15(20).

PMID: 37894297 PMC: 10605760. DOI: 10.3390/cancers15204930.

Polymer Materials for Drug Delivery and Tissue Engineering.

Hudita A, Galateanu B Polymers (Basel). 2023; 15(14).

PMID: 37514492 PMC: 10385964. DOI: 10.3390/polym15143103.

References

Ansari L, Derakhshi M, Bagheri E, Shahtahmassebi N, Malaekeh-Nikouei B . Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells. Pharm Dev Technol. 2020; 25(5):601-609. DOI: 10.1080/10837450.2020.1725045. View

Basak S, Eck S, Gutzmer R, Smith A, Birebent B, Purev E . Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector. Ann N Y Acad Sci. 2000; 910:237-52; discussion 252-3. DOI: 10.1111/j.1749-6632.2000.tb06712.x. View

Wu P, Zhu H, Zhuang Y, Sun X, Gu N . Combined Therapeutic Effects of I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer. Int J Nanomedicine. 2020; 15:2777-2787. PMC: 7185645. DOI: 10.2147/IJN.S215137. View

Vaupel P, Kallinowski F, Okunieff P . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49(23):6449-65. View

Vlahov I, Leamon C . Engineering folate-drug conjugates to target cancer: from chemistry to clinic. Bioconjug Chem. 2012; 23(7):1357-69. DOI: 10.1021/bc2005522. View

Osorio M, Martinez E, Naranjo T, Castro C . Recent Advances in Polymer Nanomaterials for Drug Delivery of Adjuvants in Colorectal Cancer Treatment: A Scientific-Technological Analysis and Review. Molecules. 2020; 25(10). PMC: 7288015. DOI: 10.3390/molecules25102270. View

Kim J . Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol. 2015; 21(17):5158-66. PMC: 4419056. DOI: 10.3748/wjg.v21.i17.5158. View

Graf C, Gao Q, Schutz I, Njiki Noufele C, Ruan W, Posselt U . Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells. Langmuir. 2012; 28(20):7598-613. DOI: 10.1021/la204913t. View

Limbach L, Li Y, Grass R, Brunner T, Hintermann M, Muller M . Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol. 2005; 39(23):9370-6. DOI: 10.1021/es051043o. View

10.

Ong S, Chitneni M, Lee K, Ming L, Yuen K . Evaluation of Extrusion Technique for Nanosizing Liposomes. Pharmaceutics. 2016; 8(4). PMC: 5198018. DOI: 10.3390/pharmaceutics8040036. View

11.

McDonald D, Baluk P . Significance of blood vessel leakiness in cancer. Cancer Res. 2002; 62(18):5381-5. View

12.

Cunningham D, Lang I, Marcuello E, Lorusso V, Ocvirk J, Shin D . Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol. 2013; 14(11):1077-1085. DOI: 10.1016/S1470-2045(13)70154-2. View

13.

Wang J, Li S, Liu Y, Zhang C, Li H, Lai B . Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis. Cancer Med. 2019; 9(1):361-373. PMC: 6943094. DOI: 10.1002/cam4.2673. View

14.

Kapalczynska M, Kolenda T, Przybyla W, Zajaczkowska M, Teresiak A, Filas V . 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci. 2018; 14(4):910-919. PMC: 6040128. DOI: 10.5114/aoms.2016.63743. View

15.

Qian K, Wu J, Zhang E, Zhang Y, Fu A . Biodegradable double nanocapsule as a novel multifunctional carrier for drug delivery and cell imaging. Int J Nanomedicine. 2015; 10:4149-57. PMC: 4487237. DOI: 10.2147/IJN.S83731. View

16.

Zhang X, Zhao M, Cao N, Qin W, Zhao M, Wu J . Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment. Biomater Sci. 2020; 8(7):1885-1896. DOI: 10.1039/c9bm01927h. View

17.

Okazaki F, Matsunaga N, Okazaki H, Utoguchi N, Suzuki R, Maruyama K . Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice. Cancer Res. 2010; 70(15):6238-46. DOI: 10.1158/0008-5472.CAN-10-0184. View

18.

Sardoiwala M, Kushwaha A, Dev A, Shrimali N, Guchhait P, Karmakar S . Hypericin-Loaded Transferrin Nanoparticles Induce PP2A-Regulated BMI1 Degradation in Colorectal Cancer-Specific Chemo-Photodynamic Therapy. ACS Biomater Sci Eng. 2021; 6(5):3139-3153. DOI: 10.1021/acsbiomaterials.9b01844. View

19.

Nikolouzakis T, Stivaktakis P, Apalaki P, Kalliantasi K, Sapsakos T, Spandidos D . Effect of systemic treatment on the micronuclei frequency in the peripheral blood of patients with metastatic colorectal cancer. Oncol Lett. 2019; 17(3):2703-2712. PMC: 6365930. DOI: 10.3892/ol.2019.9895. View

20.

Lopez A, Cacoub P, Macdougall I, Peyrin-Biroulet L . Iron deficiency anaemia. Lancet. 2015; 387(10021):907-16. DOI: 10.1016/S0140-6736(15)60865-0. View